BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15031284)

  • 1. Characterization of recombinant, membrane-attached full-length prion protein.
    Eberl H; Tittmann P; Glockshuber R
    J Biol Chem; 2004 Jun; 279(24):25058-65. PubMed ID: 15031284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structural characterization of a mimetic membrane-anchored prion protein.
    Hicks MR; Gill AC; Bath IK; Rullay AK; Sylvester ID; Crout DH; Pinheiro TJ
    FEBS J; 2006 Mar; 273(6):1285-99. PubMed ID: 16519692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane environment alters the conformational structure of the recombinant human prion protein.
    Morillas M; Swietnicki W; Gambetti P; Surewicz WK
    J Biol Chem; 1999 Dec; 274(52):36859-65. PubMed ID: 10601237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes.
    Chu NK; Shabbir W; Bove-Fenderson E; Araman C; Lemmens-Gruber R; Harris DA; Becker CF
    J Biol Chem; 2014 Oct; 289(43):30144-60. PubMed ID: 25217642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cell-surface prion protein relative to its recombinant analogue: insights from molecular dynamics simulations of diglycosylated, membrane-bound human prion protein.
    DeMarco ML; Daggett V
    J Neurochem; 2009 Apr; 109(1):60-73. PubMed ID: 19226372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering the prion protein using chemical synthesis.
    Ball HL; King DS; Cohen FE; Prusiner SB; Baldwin MA
    J Pept Res; 2001 Nov; 58(5):357-74. PubMed ID: 11892845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
    Bate C; Nolan W; Williams A
    J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of prion proteins to lipid membranes.
    Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
    Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
    Vanik DL; Surewicz WK
    J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosensing of lipid-prion interactions: insights on charge effect, Cu(II)-ions binding and prion oligomerization.
    Steunou S; Chich JF; Rezaei H; Vidic J
    Biosens Bioelectron; 2010 Dec; 26(4):1399-406. PubMed ID: 20692152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the properties and trafficking of an anchorless form of the prion protein.
    Campana V; Caputo A; Sarnataro D; Paladino S; Tivodar S; Zurzolo C
    J Biol Chem; 2007 Aug; 282(31):22747-56. PubMed ID: 17556367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
    Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
    Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semisynthesis of membrane-attached prion proteins.
    Chu NK; Becker CF
    Methods Enzymol; 2009; 462():177-93. PubMed ID: 19632475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liberation of GPI-anchored prion from phospholipids accelerates amyloidogenic conversion.
    Lin SJ; Yu KH; Wu JR; Lee CF; Jheng CP; Chen HR; Lee CI
    Int J Mol Sci; 2013 Sep; 14(9):17943-57. PubMed ID: 24005859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant expression of soluble murine prion protein for C-terminal modification.
    Chu NK; Becker CF
    FEBS Lett; 2013 Mar; 587(5):430-5. PubMed ID: 23337878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform.
    Baron GS; Caughey B
    J Biol Chem; 2003 Apr; 278(17):14883-92. PubMed ID: 12594216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.